BLFSBioLife Solutions, Inc.

$921M

FY 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$48M+75.7% YoY

Gross Profit

$27M57.1% margin

Operating Income

-$3M-6.9% margin

Net Income

$3M5.5% margin

EPS (Diluted)

$-0.06

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$2M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$235M

Total Liabilities

$30M

Stockholders' Equity

$205M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$27M	+75.7%
Gross Profit	$27M	$19M	+48.2%
Operating Income	-$3M	-$781,000	-326.6%
Net Income	$3M	-$2M	+261.0%

BLFS FY 2020 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena